In an interview, C. Ola Landgren, MD, PhD, delved into the details of the FDA's draft guidance on using MRD as a basis for ...

Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...

News headlines often compress complex science into a simple storyline: If two things are happening at the same time, one must ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in breast cancer patients can interact and drive resistance to certain drugs ...

Far Far West's frantic gunfights earn a hearty yeehaw from me.

A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, ...

Transcript: Rare Diseases ...

New findings show how inherited and acquired genetic mutations cause breast cancer resistance to CDK4/6 inhibitors.

An informational industry analysis examining ingredient-level research, marketing positioning trends, regulatory context, and ...

The University of Warwick, which is setting up the Registry, plans to collect data for analysis from 500 AML patients at sites in 30 large metropolitan NHS hospitals across the UK by the end of this ...

Physical exertion combined with deep concentration can severely slow down human reaction times. A recent trial reveals that ...

This afternoon, we released financial results for the quarter and full year ended December 31, 2025, and recent corporate updates. The press release is available on the Investors section of our ...